REQUEST A DEMO
Total
USD $0.00
Search more companies

K - Pharma S.R.O. (Czech Republic)

Main Activities: Motor Vehicle and Parts Dealers
Full name: K - Pharma S.R.O. Profile Updated: October 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

K - Pharma S.R.O. is a company based in Czech Republic, with its head office in Prague. It operates in the Motor Vehicle and Parts Dealers industry. The company was established on March 05, 2007. 50 - 99 (2023) employees currently work for K - Pharma S.R.O.. There was a net sales revenue increase of 13.13% reported in K - Pharma S.R.O.’s latest financial highlights for 2022. Its total assets grew by 0.38% over the same period. In 2022, K - Pharma S.R.O.’s net profit margin increased by 0.65%.

Headquarters
Karlovo namesti 292/14
Prague; The City of Prague; Postal Code: 12000

Contact Details: Purchase the K - Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the K - Pharma S.R.O. report to view the information.
Outstanding Shares:
Purchase the K - Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the K - Pharma S.R.O. report to view the information.
Incorporation Date:
March 05, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Venea S.R.O.
100%
Company Performance
Financial values in the chart are available after K - Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
13.13%
Total operating revenue
11.42%
Operating profit (EBIT)
531.25%
Net Profit (Loss) for the Period
692%
Total assets
0.38%
Total equity
36.33%
Operating Profit Margin (ROS)
0.64%
Net Profit Margin
0.65%
Return on Equity (ROE)
22.06%
Debt to Equity Ratio
-238.06%
Quick Ratio
0.05%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?